| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 2.04e-03 | 61 | 23 | 2 | GO:0000307 | |
| GeneOntologyCellularComponent | dendritic shaft | 2.98e-03 | 74 | 23 | 2 | GO:0043198 | |
| Domain | Cyclin_C-dom | 1.95e-04 | 17 | 23 | 2 | IPR004367 | |
| Domain | Cyclin_C | 1.95e-04 | 17 | 23 | 2 | PF02984 | |
| Domain | Cyclin_C | 1.95e-04 | 17 | 23 | 2 | SM01332 | |
| Domain | PWWP | 2.72e-04 | 20 | 23 | 2 | SM00293 | |
| Domain | PWWP | 3.61e-04 | 23 | 23 | 2 | PF00855 | |
| Domain | PWWP_dom | 3.61e-04 | 23 | 23 | 2 | IPR000313 | |
| Domain | PWWP | 3.94e-04 | 24 | 23 | 2 | PS50812 | |
| Domain | CYCLINS | 5.38e-04 | 28 | 23 | 2 | PS00292 | |
| Domain | Cyclin_N | 7.48e-04 | 33 | 23 | 2 | IPR006671 | |
| Domain | Cyclin_N | 7.48e-04 | 33 | 23 | 2 | PF00134 | |
| Domain | CYCLIN | 9.93e-04 | 38 | 23 | 2 | SM00385 | |
| Domain | - | 1.10e-03 | 40 | 23 | 2 | 1.10.472.10 | |
| Domain | Cyclin-like | 1.27e-03 | 43 | 23 | 2 | IPR013763 | |
| Domain | Zinc_finger_PHD-type_CS | 2.88e-03 | 65 | 23 | 2 | IPR019786 | |
| Domain | PHD | 3.81e-03 | 75 | 23 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 4.22e-03 | 79 | 23 | 2 | IPR019787 | |
| Domain | PH | 4.63e-03 | 278 | 23 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 4.68e-03 | 279 | 23 | 3 | PS50003 | |
| Domain | PH_domain | 4.73e-03 | 280 | 23 | 3 | IPR001849 | |
| Domain | PHD | 5.32e-03 | 89 | 23 | 2 | SM00249 | |
| Domain | Znf_PHD | 5.56e-03 | 91 | 23 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.04e-03 | 95 | 23 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 6.17e-03 | 96 | 23 | 2 | PS01359 | |
| Domain | zf-C2H2_6 | 6.50e-03 | 314 | 23 | 3 | PF13912 | |
| Domain | - | 1.18e-02 | 391 | 23 | 3 | 2.30.29.30 | |
| Domain | Znf_FYVE_PHD | 1.40e-02 | 147 | 23 | 2 | IPR011011 | |
| Domain | PH_dom-like | 1.49e-02 | 426 | 23 | 3 | IPR011993 | |
| Domain | - | 1.71e-02 | 449 | 23 | 3 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.81e-02 | 459 | 23 | 3 | IPR013083 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M | 7.84e-06 | 5 | 13 | 2 | M49022 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M | 1.64e-05 | 7 | 13 | 2 | M47574 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 2.82e-05 | 9 | 13 | 2 | M47586 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 3.52e-05 | 10 | 13 | 2 | M47572 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M | 4.30e-05 | 11 | 13 | 2 | M47573 | |
| Pathway | WP_P53_SIGNALING | 1.58e-03 | 65 | 13 | 2 | MM15852 | |
| Pathway | KEGG_P53_SIGNALING_PATHWAY | 1.73e-03 | 68 | 13 | 2 | M6370 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE | 1.78e-03 | 69 | 13 | 2 | M39339 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 1.93e-03 | 72 | 13 | 2 | MM15381 | |
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 7474080 | ||
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 10958988 | ||
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 11878934 | ||
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 7666531 | ||
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 9094673 | ||
| Pubmed | 6.83e-06 | 6 | 24 | 2 | 7474100 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 9520381 | ||
| Pubmed | HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. | 9.56e-06 | 7 | 24 | 2 | 9560267 | |
| Pubmed | 1.91e-05 | 493 | 24 | 5 | 15368895 | ||
| Pubmed | 3.00e-05 | 12 | 24 | 2 | 7494303 | ||
| Pubmed | 4.13e-05 | 14 | 24 | 2 | 26912663 | ||
| Pubmed | 1.47e-04 | 26 | 24 | 2 | 11531413 | ||
| Pubmed | Effects of Pparγ1 deletion on late-stage murine embryogenesis and cells that undergo endocycle. | 1.83e-04 | 29 | 24 | 2 | 34246625 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 4.54e-04 | 533 | 24 | 4 | 30554943 | |
| Pubmed | 5.02e-04 | 227 | 24 | 3 | 26410627 | ||
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 5.26e-04 | 49 | 24 | 2 | 9630514 | |
| Cytoband | 3q26.2 | 9.12e-05 | 27 | 24 | 2 | 3q26.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q33 | 3.82e-04 | 55 | 24 | 2 | chr13q33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q26 | 5.68e-03 | 216 | 24 | 2 | chr3q26 | |
| GeneFamily | Cyclins | 2.74e-04 | 28 | 16 | 2 | 473 | |
| GeneFamily | PHD finger proteins | 2.81e-03 | 90 | 16 | 2 | 88 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.40e-02 | 206 | 16 | 2 | 682 | |
| GeneFamily | EF-hand domain containing | 1.57e-02 | 219 | 16 | 2 | 863 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.37e-02 | 718 | 16 | 3 | 28 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 2.69e-05 | 680 | 24 | 6 | MM456 | |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | 4.94e-05 | 454 | 24 | 5 | M19927 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#2_top-relative-expression-ranked_500 | 1.69e-05 | 139 | 24 | 4 | gudmap_kidney_e10.5_UretericTip_HoxB7_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 1.69e-05 | 1459 | 24 | 9 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.20e-05 | 532 | 24 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 4.62e-05 | 1257 | 24 | 8 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.55e-04 | 469 | 24 | 5 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_100 | 2.07e-04 | 19 | 24 | 2 | gudmap_developingGonad_e18.5_ovary_100_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 3.47e-04 | 1252 | 24 | 7 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.04e-04 | 316 | 24 | 4 | gudmap_kidney_P3_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_100 | 4.88e-04 | 29 | 24 | 2 | gudmap_developingGonad_e16.5_ovary_100_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_200 | 5.58e-04 | 31 | 24 | 2 | gudmap_developingGonad_e14.5_ ovary_200_k3 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.81e-04 | 348 | 24 | 4 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.99e-05 | 134 | 24 | 3 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 158 | 24 | 3 | d72d6527dc50207ddbada262460d3c4bac249a19 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.77e-05 | 168 | 24 | 3 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 168 | 24 | 3 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 174 | 24 | 3 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 174 | 24 | 3 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 175 | 24 | 3 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.18e-04 | 179 | 24 | 3 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 180 | 24 | 3 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic-Meg|bone_marrow / Manually curated celltypes from each tissue | 1.20e-04 | 180 | 24 | 3 | 44ba37bead1ac39bce4d3eef00961063c50ced0d | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 184 | 24 | 3 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 184 | 24 | 3 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.30e-04 | 185 | 24 | 3 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 185 | 24 | 3 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 24 | 3 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 186 | 24 | 3 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 24 | 3 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 24 | 3 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 24 | 3 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 187 | 24 | 3 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 188 | 24 | 3 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-04 | 189 | 24 | 3 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 24 | 3 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.47e-04 | 193 | 24 | 3 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 194 | 24 | 3 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-04 | 194 | 24 | 3 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 1.49e-04 | 194 | 24 | 3 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.49e-04 | 194 | 24 | 3 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-04 | 194 | 24 | 3 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.49e-04 | 194 | 24 | 3 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 194 | 24 | 3 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.52e-04 | 195 | 24 | 3 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.52e-04 | 195 | 24 | 3 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.52e-04 | 195 | 24 | 3 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.54e-04 | 196 | 24 | 3 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 1.56e-04 | 197 | 24 | 3 | acd678586aa0e4375bc8fbcdaa1a796c8dd23885 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.56e-04 | 197 | 24 | 3 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-04 | 197 | 24 | 3 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.56e-04 | 197 | 24 | 3 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.56e-04 | 197 | 24 | 3 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.56e-04 | 197 | 24 | 3 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-04 | 197 | 24 | 3 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.56e-04 | 197 | 24 | 3 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-04 | 197 | 24 | 3 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-04 | 197 | 24 | 3 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-04 | 197 | 24 | 3 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 197 | 24 | 3 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.56e-04 | 197 | 24 | 3 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.59e-04 | 198 | 24 | 3 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 198 | 24 | 3 | f801157468e59b5d049f703feadc9bb0f11e85cc | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-04 | 198 | 24 | 3 | 36897e17de2e22ee6b23920ee6e60931903f3e5c | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.59e-04 | 198 | 24 | 3 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.61e-04 | 199 | 24 | 3 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 1.61e-04 | 199 | 24 | 3 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.61e-04 | 199 | 24 | 3 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.61e-04 | 199 | 24 | 3 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.61e-04 | 199 | 24 | 3 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 1.61e-04 | 199 | 24 | 3 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.63e-04 | 200 | 24 | 3 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.63e-04 | 200 | 24 | 3 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | 0bba93f1271dac704dddcdea8cb0f84a7ac6f42a | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | c9479452ab8c51139522383f745f02171ebbd7e2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.56e-04 | 52 | 24 | 2 | d654e2b77c53ed5319015598b68a20bf4416380c | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.06e-04 | 62 | 24 | 2 | 91c49ae176d2a418a58398e9d5e55c77187cc2fb | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.06e-04 | 62 | 24 | 2 | 3275775572a65460b6248ee72b4c85e4d4dee424 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Tuba1c))|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.33e-03 | 101 | 24 | 2 | 0b32e6071f05dbe808e51e18c3a3f8221f438f83 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.52e-03 | 108 | 24 | 2 | 63d45cc3ee149a7baf255b70409f8ea54c56157b | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.52e-03 | 108 | 24 | 2 | d57eeda825b6e0e64bae185896ae7eea6a2a50e9 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.52e-03 | 108 | 24 | 2 | db8472616886c6195f8c27c00f00133a9c10691d | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.52e-03 | 108 | 24 | 2 | c2aa6bf8554bfb6b0f9c5f6658601c6cf7c8bdbc | |
| ToppCell | (05)_Ciliated-(3)_72hpi|(05)_Ciliated / shred by cell type and Timepoint | 1.66e-03 | 113 | 24 | 2 | eaa5bc8f8183b353ee1e7618e99220eb3684cd60 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.72e-03 | 115 | 24 | 2 | 15b2c11225802cc15c01165d84a755432f02d82f | |
| ToppCell | Control-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.87e-03 | 120 | 24 | 2 | 695dab6b01ad2c33cdcaf92bb9996ff2899ef77e | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.00e-03 | 124 | 24 | 2 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.06e-03 | 126 | 24 | 2 | 84dce108561d4b745d19250c2ac0667d9e4ea17d | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Hist1h2al)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.06e-03 | 126 | 24 | 2 | 6072996987f7b05949adb86c9433e3302c4441d2 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-03 | 129 | 24 | 2 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | Ionocyte-iono-4|World / Class top | 2.16e-03 | 129 | 24 | 2 | 85ee6e16959cb58a58f5b09edf1f78d9ce6a9441 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-03 | 129 | 24 | 2 | ff74d159034a09f7b174da18bfb9a26936252b4c | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-03 | 130 | 24 | 2 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.19e-03 | 130 | 24 | 2 | 92913960e4367261ba08a405b61a421bc5e18169 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Cdc20)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.23e-03 | 131 | 24 | 2 | f9fb8d74ca720b81fd5910cc975510359a8ef751 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-03 | 132 | 24 | 2 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Proliferative_AT1_Progenitor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.29e-03 | 133 | 24 | 2 | b0d3ac5abd9ebd490db46a3ef2e4ae88c4bf4e34 | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|RA / Chamber and Cluster_Paper | 2.33e-03 | 134 | 24 | 2 | 60ee3accc54108e5b9a0018f6aa8488dc39d5ade | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.36e-03 | 135 | 24 | 2 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-7|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.40e-03 | 136 | 24 | 2 | d94f0fbeb7b80d4cf0687d1924ebf8f9dd07358c | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.47e-03 | 138 | 24 | 2 | 5a713f24f633de463ef47ca37fbb2bb60c7fdb77 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-03 | 141 | 24 | 2 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-03 | 141 | 24 | 2 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-03 | 142 | 24 | 2 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-03 | 142 | 24 | 2 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-03 | 142 | 24 | 2 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | MS-CD8-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 2.61e-03 | 142 | 24 | 2 | 7591491520a883bb09fa2b8d0a20ae2abd2b8703 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-03 | 143 | 24 | 2 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-03 | 143 | 24 | 2 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | IIF-Lymphocyte-T_NK-dnT|IIF / Disease, Lineage and Cell Type | 2.75e-03 | 146 | 24 | 2 | d0f361662db5f7be26104346e8431f7e30c5ce3a | |
| Drug | Pyrazolopyridazine 1a | 1.06e-05 | 5 | 24 | 2 | CID006263849 | |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A | 4.85e-05 | 195 | 24 | 4 | 2085_UP | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 6757_DN | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; HL60; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 2441_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 6692_DN | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 1810_UP | |
| Drug | GR63799 | 6.98e-05 | 12 | 24 | 2 | CID005311224 | |
| Drug | aloisine A | 8.25e-05 | 13 | 24 | 2 | CID005326843 | |
| Disease | multiple myeloma | 1.02e-04 | 112 | 24 | 3 | EFO_0001378 | |
| Disease | insomnia measurement | 4.20e-04 | 443 | 24 | 4 | EFO_0007876 | |
| Disease | preeclampsia | 1.83e-03 | 78 | 24 | 2 | EFO_0000668 | |
| Disease | sleep duration | 3.06e-03 | 362 | 24 | 3 | EFO_0005271 | |
| Disease | interleukin-6 measurement | 3.73e-03 | 112 | 24 | 2 | EFO_0004810 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 4.41e-03 | 122 | 24 | 2 | EFO_0009264, EFO_0010724 | |
| Disease | emphysema imaging measurement | 6.25e-03 | 146 | 24 | 2 | EFO_0007626 | |
| Disease | cervical carcinoma | 9.55e-03 | 182 | 24 | 2 | EFO_0001061 | |
| Disease | diet measurement | 9.56e-03 | 1049 | 24 | 4 | EFO_0008111 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSKHTKSSKHNKKRS | 11 | Q9NWB6 | |
| KKRFKSLEKSHKNTG | 3676 | Q8TCU4 | |
| HKLSSLKKKCTIYGK | 281 | Q8WWL7 | |
| KKSTSHGKVFFLKKQ | 751 | Q8WWL7 | |
| SQYKLRKSSHLKKLN | 21 | Q9Y250 | |
| HKKRSSSKNTKLKGY | 636 | Q6NUN7 | |
| LHSYTKLKGQKKSAR | 246 | O96028 | |
| NSYTDIKNLKKHKTK | 506 | Q9NPC7 | |
| TLKRTGKSKYKFRNH | 701 | A8MYU2 | |
| KAGSKRKKSYTSKKS | 141 | Q9Y3E1 | |
| KNKYATSKHAKISTL | 401 | P14635 | |
| SGTINHKKYIKFSKT | 31 | Q8IY85 | |
| STRKHRKKCKSYLKT | 2316 | Q8NDH2 | |
| SHKSRKYRSSSKMKS | 6861 | Q8NDH2 | |
| KKSTKRTKSINGSLY | 311 | Q8TCU6 | |
| LRKSKSRSKKNHSKF | 81 | Q53GL0 | |
| KHSDTKKNTKKRHSF | 291 | Q7Z6J0 | |
| YHFSKLKKSKRGSNR | 196 | P55197 | |
| GRTSSKAKSKSKHKQ | 741 | Q8TBB6 | |
| TFGFGALSKHTKKKK | 426 | Q5T4D3 | |
| NFKKNKGYHKLLTKS | 951 | Q7Z2Z1 | |
| SNQKKKSLKSYSSRK | 521 | Q5T4T6 | |
| NFGKHKKTTKSRSKS | 551 | Q4KWH8 | |
| KHGTYKTIGNRKKKT | 391 | Q6IQ21 | |
| GKAFNQSSKLTKHKK | 516 | Q03923 | |
| KHKSYKTSGEKKCLS | 1091 | Q9BXT5 |